Identification |
Name: | Toremifene citrate |
Synonyms: | 2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]-N,N-dimethyl-ethanamine; 2-hydroxypropane-1,2,3-tricarboxylic acid;Ethanamine,2-[4-[(1Z)-4-chloro-1,2- diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);{(Z)-2-[4-(4-Chloro-1,} 2-diphenyl-1-butenyl)phenoxy]-N,N- dimethylethanamine, 2-hydroxy-1,2,3-propanetricarboxylate (1:1);Fareston (TN);(Z)-4-Chloro-1,2-diphenyl-1-(4-(2-(N,N-dimethylamino)ethoxy)phenyl)-1-butene citrate (1:1);2-[p-[ (Z)-4-chloro-1,2-diphenyl-1-butenyl]phenoxy]-N,N- dimethylethylamine citrate (1:1);FC 1157a;2-[p-[(Z)-4-Chloro-1,2-diphenyl-1-butenyl]phenoxy]-N,N- dimethylethylamine citrate (1:1);Toremifene citrate [USAN];Toremifene citrate (JAN/USAN);Fareston; |
CAS: | 89778-27-8 |
Molecular Formula: | C26H28ClNO.C6H8O7 |
Molecular Weight: | 598.09 |
InChI: | InChI=1/C26H28ClNO.C6H8O7/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-16H,17-20H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b26-25-; |
Molecular Structure: |
|
Properties |
Melting Point: | 158-164 oC |
Flash Point: | 277.4 oC |
Boiling Point: | 535.1 oC at 760 mmHg |
Density: | 1.045g/cm3 |
Refractive index: | 1,416-1,418 |
Appearance: | White or almost white powder |
Specification: | White-to-Off-White Solid usageEng:An antiestrogen and antineoplastic. Nonsteroidal antiestrogen structurally similar to Tamoxifen. Safety Statements:26-37/39 26:In case of contact with eyes, rinse immediately with plenty
of water and seek medical advice 37/39:Wear suitable protective clothing, gloves and eye/face
protection |
Flash Point: | 277.4 oC |
Usage: | An antiestrogen and antineoplastic. Nonsteroidal antiestrogen structurally similar to Tamoxifen. |
Safety Data |
Hazard Symbols |
Xi: Irritant
|
|
|